The Pharma Data

MARCH 23, 2022

Roche today announced the donation of additional medicines and diagnostics to Ukraine. Beyond the already communicated 150,000 packs of an antibiotic medicine the new donation includes another 4,600 packs of specialized medicines for the treatment of influenza, rheumatoid arthritis, SMA and various cancers.

Medicine 52

Medicine In-Vitro Reagent Branding 52

pharmaphorum

AUGUST 16, 2020

Driven by technological advances and the development of precision medicines, these modernization initiatives are designed to propel laboratory efficiencies into the future, allowing scientists to spend more time on science. Each Swittons device can be custom branded, and programmed for a wide range of laboratory scenarios.

Life Science 129

Life Science Reagent Scientist Clinical Trials 129

pharmaphorum

JUNE 1, 2021

Pharmaceutical companies are accountable for ensuring that their medicine is safe when it comes into the hands of patients. Specific apps could also alert healthcare providers if vulnerable patients are failing to scan their medicine. This technology can also play an important role in supporting virtual clinical trials.

Medicine 52

Medicine DNA Pharmacy Production 52

The Pharma Data

MARCH 16, 2022

3, and Delta ([link] About TIB Molbiol TIB Molbiol is a subsidiary of Roche Diagnostics that has supplied the global market with reagents for research and medical diagnostics for over 30 years. These kits can detect and differentiate between Omicron subvariants BA.1, The majority of assays are used to test for infectious diseases.

In-Vitro 52

In-Vitro Genotype Reagent Protein 52

The Pharma Data

MAY 15, 2023

She is also a board member at BBI Solutions, a UK based diagnostic reagents and a Novo Holdings company. Shamiram holds an AB from Smith College and Doctor of Medicine as well as a Master of Public Health, both from Emory University, U.S.A. About Novartis Novartis is reimagining medicine to improve and extend people’s lives.

Sales 40

Sales Production Doctor Doctors 40

XTalks

OCTOBER 1, 2020

Prior to starting Fountain Therapeutics in 2018, with co-founders Tom Rando, MD, PhD and Tom Cheung, PhD, Dr. Rodgers was an assistant professor at The Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at the Keck School of Medicine of The University of Southern California (USC).

Scientist 52

Scientist In-Vitro Research Life Science 52